Literature DB >> 7021547

Islet-activating protein. A modifier of receptor-mediated regulation of rat islet adenylate cyclase.

T Katada, M Ui.   

Abstract

Adenylate cyclase of the membrane-rich fraction of 24-h cultured islets was inhibited by epinephrine via alpha-adrenergic receptors. Epinephrine was inhibitory only when the enzyme was activated by GTP; the degree of inhibition was highly proportional to the degree of GTP activation. Adenylate cyclase of islets cultured with islet-activating protein (IAP), one of the pertussis toxins, was less susceptible to epinephrine inhibition. The degree of the inhibition was markedly reduced without changes in potency of the catecholamine and in GTP dependence after IAP treatment. None of the other kinetic properties of the enzyme including the affinity for substrate, sensitivity to guanine nucleotide and fluoride activation, and cholera toxin-induced modification of enzymic activity were affected by treatment of islets with IAP, suggesting that neither the catalytic nor the GTP-regulatory component of the membrane adenylate cyclase complex is the site of IAP action. Slight activation of the enzyme by glucagon or adenosine tended to be enhanced by IAP treatment. Thus, a mechanism whereby membrane receptors are linked to adenylate cyclase appears to be modified by exposure of islet cells to IAP.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021547

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The discovery of signal transduction by G proteins: a personal account and an overview of the initial findings and contributions that led to our present understanding.

Authors:  Lutz Birnbaumer
Journal:  Biochim Biophys Acta       Date:  2006-10-04

2.  Different G proteins mediate the opioid inhibition or enhancement of evoked [5-methionine]enkephalin release.

Authors:  A R Gintzler; H Xu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Post-priming actions of ATP on Ca2+-dependent exocytosis in pancreatic beta cells.

Authors:  N Takahashi; T Kadowaki; Y Yazaki; G C Ellis-Davies; Y Miyashita; H Kasai
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Augmented glucose-induced insulin release in mice lacking G(o2), but not G(o1) or G(i) proteins.

Authors:  Ying Wang; Sangeun Park; Neil S Bajpayee; Yoshiko Nagaoka; Guylain Boulay; Lutz Birnbaumer; Meisheng Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 5.  Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins.

Authors:  G Milligan
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

6.  The action of islet activating protein (pertussis toxin) on insulin's ability to inhibit adenylate cyclase and activate cyclic AMP phosphodiesterases in hepatocytes.

Authors:  C M Heyworth; A M Grey; S R Wilson; E Hanski; M D Houslay
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

7.  Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr-25000 protein in rat liver plasma membranes.

Authors:  C M Heyworth; A D Whetton; S Wong; B R Martin; M D Houslay
Journal:  Biochem J       Date:  1985-06-15       Impact factor: 3.857

Review 8.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

9.  Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse.

Authors:  C A Re; M C Veroni; R G Larkins
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

10.  Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.

Authors:  A J de Brum-Fernandes; S Morisset; G Bkaily; C Patry
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.